Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extended Follow-up Study of the Efficacy and Safety of De-escalated Antiplatelet Therapy After Coronary Artery Bypass Grafting (TOP-CABG FE)

NCT07871591 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.

NCT NCT07871591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07871591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extended Follow-up Study of the Efficacy and Safety of De-escalated Antiplatelet Therapy After Coronary Artery Bypass Grafting (TOP-CABG FE)
Lead sponsor
China National Center for Cardiovascular Diseases
Phase
Observational
Overall status
Not yet recruiting
Start date
October 15, 2026
Completion date
June 30, 2028
Enrollment
2,290 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, coronary artery bypass grafting, coronary artery disease, dual antiplatelet therapy, myocardial infarction, myocardial ischemia